Core Viewpoint - Bleichmar Fonti & Auld LLP is investigating Olo Inc. and its leadership for potential breaches of fiduciary duties related to the company's pending acquisition by Thoma Bravo at a price of $10.25 per share, which values Olo at approximately $2 billion in equity [1][3][4]. Company Overview - Olo Inc. operates an open SaaS platform designed for restaurants, facilitating digital commerce operations such as ordering, delivery, engagement, and payments [3]. - The company's stock is divided into Class A and Class B shares, with Class B shares having ten votes per share compared to one vote for Class A shares. As of December 31, 2024, directors and executive officers collectively owned about 82% of the voting power of Olo's outstanding capital stock [3]. Acquisition Details - On July 3, 2025, Olo announced a definitive agreement to be acquired by Thoma Bravo in an all-cash transaction, with shareholders set to receive $10.25 per share [3]. - The purchase price represents a 65% premium over Olo's unaffected share price of $6.20 as of April 30, 2025 [3]. Legal Investigation - The investigation by BFA Law focuses on whether Olo's board of directors, executive officers, and CEO Noah H. Glass acted in the best interests of shareholders during the merger process [4].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against West Pharmaceutical Services, Inc. due to allegations of fiduciary duty breaches by the board of directors following a class action complaint filed on June 20, 2025 [1] Company Overview - West Pharmaceutical Services, Inc. is a medical supplies company based in Exton, Pennsylvania, serving as a key supplier to the pharmaceutical, biotechnology, and generic drug industries [2] Allegations and Issues - The class action complaint alleges that West failed to disclose significant destocking issues in its high-margin High-Value Products portfolio, despite claiming strong visibility into customer demand [2] - The SmartDose device, positioned as a high-margin growth product, was found to be dilutive to profit margins due to operational inefficiencies [2] - Margin pressures raised the risk of costly restructuring activities, including the exit from continuous glucose monitoring contracts with long-standing customers [2] - Positive statements made by the company regarding its business and prospects were claimed to be materially false or misleading [2] Disclosure of Financial Issues - The truth about the alleged fraud was revealed on February 13, 2025, when West issued weak revenue and earnings forecasts for 2025, attributing the disappointing guidance to contract manufacturing headwinds and the loss of two major customers [3] - West indicated that its SmartDose devices would be margin-dilutive in 2025 and mentioned plans to improve the device's economics [3] - Following this disclosure, West's stock price dropped by $123.17 per share, a decline of 38%, closing at $199.11 on February 13, 2025 [3]

Group 1 - Halper Sadeh LLC is investigating TuHURA Biosciences, Inc. (NASDAQ: HURA) for potential violations related to its merger with Kineta, Inc. [1] - Vigil Neuroscience, Inc. (NASDAQ: VIGL) is under scrutiny due to its sale to Sanofi, where shareholders will receive $8.00 per share in cash and a contingent value right for an additional $2.00 per share based on the commercial sale of VG-3927 [1] - The firm may seek increased consideration for shareholders and additional disclosures regarding the proposed transactions [2] Group 2 - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options at no cost [3] - The firm represents investors globally who have experienced securities fraud and corporate misconduct, recovering millions for defrauded investors [3]

Core Viewpoint - The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Harley-Davidson, Inc. regarding possible breaches of fiduciary duties to shareholders and allegations of gross mismanagement of the company [1]. Group 1 - The investigation focuses on whether the board of directors of Harley-Davidson has acted in the best interests of shareholders [1]. - Shareholders are encouraged to participate in the investigation if they hold shares in Harley-Davidson [1]. Group 2 - The Law Offices of Frank R. Cruz provides contact information for shareholders who wish to discuss their rights and interests related to the investigation [3].

Core Viewpoint - Johnson Fistel, PLLP has initiated an investigation into CareDx, Inc. for potential breaches of fiduciary duties and violations of federal securities laws [1][2]. Investigation Details - The investigation focuses on actions taken by CareDx insiders between April 30, 2020, and February 24, 2022, which involved issuing false and misleading statements about the company's compliance with healthcare laws and revenue growth [2]. - CareDx began disclosing issues on October 28, 2021, revealing that the company was under multiple government investigations and that its financial results were significantly lower than previously reported [2]. - By November 3, 2022, CareDx's share price had decreased by over 77.22% from its previous levels [2]. Shareholder Information - Current stockholders who have held CareDx stock since at least January 2021 are encouraged to contact Johnson Fistel to discuss their legal rights regarding the investigation [3].

Core Viewpoint - Johnson Fistel, PLLP is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation in relation to their obligations to shareholders [1] Group 1: Legal Investigation - The investigation is focused on claims that Masimo's Chief Financial Officer and other executives may have inflated Sound United's financial performance and misled investors regarding its integration [3] - A court ruling on November 5, 2024, partially granted and partially denied Masimo's motion to dismiss a shareholder class action lawsuit, allowing claims against the CFO to proceed while dismissing claims against other executive defendants [3] Group 2: Shareholder Rights - Current shareholders of Masimo Corporation may have legal claims that can be brought on behalf of the company against its directors and officers [2] - Shareholders who have continuously owned MASI shares are encouraged to join the investigation through a provided link [3]